Goldman Sachs Gives Neutral Rating to Oscar Health (NYSE: OSCR) Amid Strong Financials

• Goldman Sachs issued a Neutral rating for Oscar Health, setting a price target of $30.00, up from $22.00.
• Oscar Health reported robust Q2 2026 results, with revenue surging 70% year-over-year to $4.88 billion and EPS reaching $1.10, a significant turnaround from a prior loss.
• Despite strong operational improvements and profitability, quarterly revenue of $4.88 billion slightly missed analyst estimates by 0.92%, potentially influencing the Neutral rating.

On August 11, 2026, investment firm Goldman Sachs issued a Neutral rating for Oscar Health (NYSE: OSCR), indicating a hold action on the health insurance stock. Oscar Health is a leading health insurance company that leverages technology to provide innovative plans to individuals and businesses. Operating within the multi-line insurance industry, the company boasts a market capitalization of approximately $7.25 billion.

At the time of the announcement, Oscar Health's stock price was $27.97. Goldman Sachs subsequently raised its price target for Oscar Health to $30.00 from a previous target of $22.00. This upward revision reflects the company's strong financial performance and record profitability reported for the first half of 2026.

The company's second-quarter results for 2026 demonstrate significant improvement. Revenue grew 70% year-over-year to $4.88 billion. As highlighted by Zacks Investment Research, earnings per share (EPS) reached $1.10, which significantly surpassed the estimated $0.43. This marks a major turnaround from the loss of $0.89 per share reported in the same quarter last year, showcasing robust Q2 earnings.

Operational metrics also improved, supporting the positive outlook for Oscar Health. The company's medical loss ratio, a key indicator of operational efficiency measuring premium revenue spent on medical claims, improved to 79.2%. A lower ratio typically signifies better profitability. Additionally, membership grew by 46% from the previous year, reaching 2.96 million members.

For the first six months of 2026, Oscar Health generated $1.10 billion in earnings from operations and $1.00 billion in net income. Despite these strong financial results, quarterly revenue of $4.88 billion slightly missed analyst estimates by 0.92%. This minor revenue miss may have contributed to the Neutral rating, suggesting that some market expectations were not entirely met.